2017 | Laboratorio Reig Jofre - Parte 2

News and repository

25 July 2017

Reig Jofre informs about the new shares

24 July 2017

Transactions within the share buyback program

18 July 2017

Transactions within the share buyback program

10 July 2017

Transactions within the share buyback program

5 July 2017

Transactions within the liquidity contract in Q2 2017

4 July 2017

Reig Jofre informs on the end of the commitments between the Company and Naturex SA

3 July 2017

Reig Jofre informs about its scrip dividend

30 June 2017

Reig Jofre informs about second shares buy-back program

15 June 2017

Begining of the trading period of free allotment rights

8 June 2017

Conditions for the execution of the capital increase through the scrip dividend or flexible dividend

8 June 2017

Resolutions on the general shareholders’ meeting

9 May 2017

Results note: First quarter of 2017

8 May 2017

Convening of the Ordinary and Extraordinary General Shareholders’ Meeting

3 May 2017

Reig Jofre, strategic partner in the stabilization and production of the first recombinant veterinary vaccine against Leishmaniasis, by Laboratorios Leti

6 April 2017

Transactions within the liquidity contract in Q1 2017

30 March 2017

Reig Jofre inaugurates a new analytical laboratory for development and quality control

23 March 2017

Reig Jofre starts marketing of three new injectable products for hospitals

16 March 2017

Reig Jofre joins Ship2B foundation to accompany emerging companies of social impact

28 February 2017

Results preview: Year 2016

23 February 2017

Reig Jofre informs on the public deed of capital reduction